| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K09344309 |
| PharmacoGx | BRD-K09344309 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PPP1R3C | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | ABHD16B | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | FRAT2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.08 |
| mRNA | WDR49 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | IGSF21 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | ABHD17C | CTRPv2 | pan-cancer | AAC | 0.15 | 0.08 |
| mRNA | METTL21B | CTRPv2 | pan-cancer | AAC | -0.17 | 0.08 |
| mRNA | SPHAR | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | IQGAP3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.08 |
| mRNA | NYX | CTRPv2 | pan-cancer | AAC | 0.17 | 0.08 |
